HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) SHH

8.75

-0.12(-1.35%)

Updated at June 02 03:00PM

Currency In CNY

Valuation

Market Cap6.27B
Enterprise Value5.74B
P/E Ratio37.17
PEG Ratio-1.65
Price/Sales Ratio0.48
Price/Book Ratio1.66
Enterprise/Revenue0.47
Enterprise/EBITDA18.1

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue10.38B
Revenue/Share18.17
Gross Profit854.06M
EBITDA273.15M
Net Income133.84M
Diluted EPS0.23

Balance Sheet

Total Cash883.88M
Total Cash/Share1.52
Total Debt730.58M
Total Debt/Equity0.24
Current Ratio1.66
Book Value Per Share5.28

Price History

52-Week Change6.32
52-Week High18.13
52-Week Low7.12
Moving Average 50 Days9.75
Moving Average 200 Days10.27

Statistics

Average Volume10.71M
Shares Outstanding579.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.06
Last Split Factor3:2
Last Split DateJune 14, 2011